Publication:
Avidin-biotin ELISA for measurement of prothrombin in human plasma

dc.contributor.authorsKoldas, M; Uras, F
dc.date.accessioned2022-03-12T17:00:40Z
dc.date.accessioned2026-01-11T06:02:06Z
dc.date.available2022-03-12T17:00:40Z
dc.date.issued2001
dc.description.abstractIn this study, IgG was partially purified from rabbit antisera against human normal prothrombin. The presence of antibodies against prothrombin was shown by Ouchterlony's double immunodiffusion method. This IgC was adsorbed to microwells and an enzyme-linked immunosorbent assay (ELISA) method was developed by using biotinylated prothrombin. We used alkaline phosphatase as the labeling enzyme. Plasma prothrombin concentrations in 30 healthy individuals and 15 patients with liver cirrhosis were measured using this ELISA method. Prothrombin levels of the cirrhotic patients (61 +/- 36 mug/ml) were significantly lower than those of the control values (117 +/- 43 mug/ml) (P < .001). In addition to the ELISA method in the same samples, we assayed prothrombin levels by nephelometry and prothrombin activities using staphylocoagulase and chromogenic substrate. With nephelometry, in healthy individuals, a mean value of 104 +/- 17 mug/ml and, in cirrhotic patients, a mean value of 51 +/- 26 mug/ml of prothrombin levels were detected. The prothrombin activities were 10532 +/- 2429 and 2433 +/- 330 U/l, respectively. In both methods, the prothrombin values of cirrhotic patients were also significantly lower than those of the healthy individuals (P<.001). The correlation coefficient between ELISA and nephelometry was r = .90, P <less than> .01, and between ELISA and the amidolytic assay was v = .69, P < .01. Prothrombin times (PT) of cirrhotic patients (18.5 +/- 2.3 s) were significantly longer and albumin (2.3 +/- 0.5 g/dl) levels were significantly lower than those of normal values (P<.001). PT were negatively correlated with prothrombin levels assayed by ELISA (r = -.59, P <less than> .01). This enzyme immunoassay technique can be used to measure prothrombin levels in plasma. (C) 2001 Elsevier Science Ltd. All rights reserved.
dc.identifier.doi10.1016/S0049-3848(01)00257-2
dc.identifier.issn0049-3848
dc.identifier.pubmed11369415
dc.identifier.urihttps://hdl.handle.net/11424/227328
dc.identifier.wosWOS:000168734800005
dc.language.isoeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.relation.ispartofTHROMBOSIS RESEARCH
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectELISA
dc.subjectavidin-biotin
dc.subjectnephelometry
dc.subjectprothrombin
dc.subjectantibody preparation
dc.subjectIgG purification
dc.subjectliver disease
dc.subjectGAMMA-CARBOXY PROTHROMBIN
dc.subjectHEPATOCELLULAR-CARCINOMA
dc.subjectLIVER-DISEASE
dc.subjectABNORMAL PROTHROMBIN
dc.subjectALPHA-FETOPROTEIN
dc.subjectMARKER
dc.subjectCARBOXYPROTHROMBIN
dc.subjectIMMUNOASSAYS
dc.subjectDEFICIENCY
dc.titleAvidin-biotin ELISA for measurement of prothrombin in human plasma
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage227
oaire.citation.issue3
oaire.citation.startPage221
oaire.citation.titleTHROMBOSIS RESEARCH
oaire.citation.volume102

Files